Suven Q3 net down 11.5%

Revenues, however, increased 9% to Rs 131.1 crore from Rs 120.3 crore in the year ago period

B Dasarath Reddy Hyderabad
Last Updated : Feb 10 2015 | 3:07 PM IST
Hyderabad-based bio pharmaceutical company Suven Life Sciences has reported a 11.55% decline in net profit at Rs 32.2 crore for the quarter ended December, 2014 as compared with Rs 36.4 crore in the corresponding quarter previous year.

The company revenues, however, increased 9% to Rs 131.1 crore from Rs 120.3 crore in the year ago period. Net profit for the third quarter ended December, 2014 was reduced due to charge of additional depreciation computed as per Schedule II of the Companies Act 2013 effective April 1, 2014, shown, according to the company.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 10 2015 | 2:38 PM IST

Next Story